Ali Saad Al-shammari: Exploring the Role of SGLT2 Inhibitors After TAVI
Ali Saad Al-shammari, Physician and Cardiology Researcher, shared a post on LinkedIn about recent article he and his colleagues co-authored, published in European Journal of Clinical Pharmacology, adding:
“Proud to share that our systematic review and meta-analysis has been published in the European Journal of Clinical Pharmacology:
‘Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation:
a GRADE-assessed systematic review and meta-analysis.’
We conducted a PRISMA-guided review of four studies including 12,374 TAVI patients, comparing SGLT2 inhibitors with standard care.
SGLT2 inhibitor therapy was associated with lower:
All-cause mortality: RR 0.62
HF hospitalization: RR 0.67
Myocardial infarction: RR 0.83
Bleeding events: RR 0.81
No significant differences were observed for cardiac death, stroke, pacemaker implantation, or AKI.
While these findings suggest a promising role for SGLT2 inhibitors after TAVI, the evidence remains limited and largely observational. Further randomized trials are needed.
Grateful to all co-authors Khadeeja ali, Yousif Kurmasha, Mohammedsadeq A. Shweliya, Muhammad Shahzaib, Atef Akoum their collaboration.”
Title: Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis
Authors: Khadeeja Ali Hamzah, Yousif Hameed Kurmasha, Ali Saad Al-Shammari, Mohammedsadeq A Shweliya, Ali Alsajad Hussein Al-Janabi, Muhammad Shahzaib, Atef Akoum, Yasar Sattar
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia